Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainAnk_2

ANKRD30A ANKRD30B MYO16

2.25e-03215233PF12796
DomainAnk

ANKRD30A ANKRD30B MYO16

2.65e-03228233PF00023
Domain-

ANKRD30A ANKRD30B MYO16

3.37e-032482331.25.40.20
DomainANK

ANKRD30A ANKRD30B MYO16

3.48e-03251233SM00248
DomainANK_REPEAT

ANKRD30A ANKRD30B MYO16

3.56e-03253233PS50088
DomainAnkyrin_rpt-contain_dom

ANKRD30A ANKRD30B MYO16

3.60e-03254233IPR020683
DomainANK_REP_REGION

ANKRD30A ANKRD30B MYO16

3.60e-03254233PS50297
DomainAnkyrin_rpt

ANKRD30A ANKRD30B MYO16

3.93e-03262233IPR002110
Pubmed

A mutation in the Srrm4 gene causes alternative splicing defects and deafness in the Bronx waltzer mouse.

SYNJ1 CACNA1D BBS9 CASK

3.40e-078524423055939
Pubmed

Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library.

ANKRD30A ANKRD30B

4.56e-07224211280766
Pubmed

A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors.

CACNA1D NFASC

8.61e-052024235224516
Pubmed

Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.

SYNJ1 CACNA1D BBS9

9.31e-0512824330995482
Pubmed

CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb repressive complex 2 via an H3K27M-like mechanism.

TRRAP SUZ12

1.14e-042324231281901
Pubmed

Identification by proximity labeling of novel lipidic and proteinaceous potential partners of the dopamine transporter.

NFASC MYO16

1.59e-042724234709416
Pubmed

The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function.

CACNA1D CASK

2.38e-043324222357600
Pubmed

GWAS of dental caries patterns in the permanent dentition.

NFASC MYO16

3.68e-044124223064961
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

NCOA2 TRRAP TSHZ2 NFASC CASK TECTA

4.22e-04148924628611215
Pubmed

Single-cell profiling of epigenetic modifiers identifies PRDM14 as an inducer of cell fate in the mammalian embryo.

PRMT9 SUZ12

4.24e-044424224183668
InteractionANKRD30A interactions

ANKRD30A ANKRD30B

3.17e-058222int:ANKRD30A
InteractionANKRD30B interactions

ANKRD30A ANKRD30B

4.08e-059222int:ANKRD30B
CytobandEnsembl 112 genes in cytogenetic band chr4q31

PRMT9 NR3C2

3.32e-03164242chr4q31
GeneFamilyAnkyrin repeat domain containing

ANKRD30A ANKRD30B MYO16

2.64e-03242213403
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

MYO16 UBN1

1.85e-02181212694
CoexpressionGSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP

SORCS2 CACNA1D BBS9 UBN1

3.04e-05199244M9269
ToppCellInfluenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class

TSHZ2 MYO16 NR3C2

7.99e-05157243287bdc4e455cd0160261a93d13538e0def49fcd4
ToppCell10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue

TRRAP PRMT9 CASK

8.93e-051632434104d3b9748b39cb0744c9be76db21bdda566a0d
ToppCellInfluenza_Severe-CD4+_Tcm|Influenza_Severe / Disease group and Cell class

TSHZ2 MYO16 CASK

1.05e-0417224347865a04968ca28c6ff125159d9a23e37c8b8af1
ToppCellCOPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class

NCOA2 TSHZ2 CASK

1.20e-0418024351a12fbad5fa7bb12e6d616a02ff9b5141e2b063
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTS20 DNAH9 MYO16

1.28e-04184243ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTS20 DNAH9 MYO16

1.28e-041842432cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTS20 DNAH9 MYO16

1.28e-041842432b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellCOPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class

NCOA2 TSHZ2 CASK

1.30e-04185243846403edd4c8f646201d519055198fc38b7ffff9
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SORCS2 MYO16 NR3C2

1.34e-04187243f6217d0dd425eac76900b44a4e48f45475f3ac36
ToppCellsevere_influenza-CD4+_Tcm|severe_influenza / disease group, cell group and cell class (v2)

TSHZ2 MYO16 CASK

1.36e-04188243633e5545f49b1b864b0ffa5fc9688d270690f884
ToppCellrenal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

SORCS2 NCOA2 NR3C2

1.38e-04189243830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TSHZ2 CACNA1D MYO16

1.38e-041892432a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

TSHZ2 CACNA1D MYO16

1.41e-041902437986586b7c82e91c71102cc8c4d7a689ae63ab4d
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SORCS2 CACNA1D MYO16

1.41e-0419024345df8fee00f8949937863159d7aa042e72748d9b
ToppCellCOPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class

NCOA2 TSHZ2 CASK

1.43e-041912433ae18bc4e3dff49b5d5958da8ebc3f747274b69c
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SORCS2 MYO16 NR3C2

1.43e-0419124396b78b4e819ea6052334bfcbc7abbf35897df885
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTS20 ANKRD30B MYO16

1.45e-04192243342842378c20267c5044bdd622515e8b9f895623
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SYNJ1 RAD51AP2 CACNA1D

1.52e-041952433e519cffa6144a62b06124642a14c9ff39b76554
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

NCOA2 NR3C2 CASK

1.54e-04196243ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster

NFASC MYO16 NR3C2

1.54e-04196243dee0984cd63a1a2fdebb4421af48ab566a5b684e
ToppCellParenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations

NCOA2 NR3C2 CASK

1.59e-041982431996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TSHZ2 MYO16 CASK

1.59e-04198243b0b0977d9482538a076b84a8dc8b15ed682662f9
ToppCellAdult-Mesenchymal|Adult / Lineage, Cell type, age group and donor

TSHZ2 CACNA1D NFASC

1.59e-0419824326e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCellInfluenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_Tcm|Influenza_Severe / Disease, condition lineage and cell class

TSHZ2 MYO16 CASK

1.59e-04198243fc99f2e300d76126d05c0c43e11cdbbeb74f6f0d
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SORCS2 TSHZ2 SPINK5

1.61e-0419924394a7867e800df352731796de8c24cba133c29622
ToppCellParenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TSHZ2 CACNA1D NFASC

1.63e-04200243cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCellMacroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic

CACNA1D MYO16 CASK

1.63e-042002434fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCellInfluenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_T_naive|Influenza_Severe / Disease, condition lineage and cell class

TSHZ2 MYO16 NR3C2

1.63e-042002430382f8fc27d18003761725e714beb6b3f3150057
ToppCellMacroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic

CACNA1D MYO16 CASK

1.63e-04200243f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCellMacroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic

CACNA1D MYO16 CASK

1.63e-04200243cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TSHZ2 CACNA1D NFASC

1.63e-04200243311fab076f2ceb258e3970eb21e39344b894042a
ToppCellMacroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic

CACNA1D MYO16 CASK

1.63e-04200243310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCellMacroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic

CACNA1D MYO16 CASK

1.63e-04200243c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCellMacroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic

CACNA1D MYO16 CASK

1.63e-04200243961858738ce35db8760c8c2e136f8369bc444ccf
ToppCellHippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Hippocampus / BrainAtlas - Mouse McCarroll V32

TSHZ2 TECTA

1.66e-031132426f270b7e59c18243e876311df721e948ce21e850
ToppCellPBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ANKRD30A MYO16

1.66e-03113242b795a0c65114b3c0758fe3720e8a80247f900971
ToppCellCOVID-19_Mild-Myeloid_G-immature_Neutrophil|COVID-19_Mild / Disease group, lineage and cell class

ANKRD30A MYO16

1.66e-03113242fc3417c379f871a4aec3edef953baaa00755c472
ToppCellPBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

ANKRD30A MYO16

1.69e-03114242613714fd15ad6d553e63d8538ad53bc1ded6bd6c
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SORCS2 NR3C2

1.69e-031142429f0c8dfd740d50448a6c91a00e7bae4dfc9b3302
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-2|TCGA-Ovary / Sample_Type by Project: Shred V9

ADAMTS20 MYO16

1.72e-03115242ecc28d8413898b893f052914fd180de9468b70e4
ToppCellCOVID-19_Mild-immature_Neutrophil-|COVID-19_Mild / Disease condition and Cell class

ANKRD30A MYO16

1.97e-031232425f19b0e32509bedeb9ac6c74ac7a20750798da5e
ToppCellCOVID-19_Mild-immature_Neutrophil|COVID-19_Mild / Disease condition and Cell class

ANKRD30A MYO16

1.97e-03123242a6670825fd8d9f9a0111a7b68598c764c99abb0d
ToppCellCOVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients

ANKRD30A MYO16

2.00e-031242425ef9eb806fb2c8ee5aae0a75503d244b08ee10d4
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CACNA1D MYO16

2.03e-03125242b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCellPBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ANKRD30A MYO16

2.06e-031262426cb89754010d64875e115da6c5805efac7a4a82d
ToppCellPBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ANKRD30A MYO16

2.06e-0312624269b2525b92d1c7c35b21cc701f5fa52a9c1b94bb
ToppCell3'_v3-bone_marrow-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|bone_marrow / Manually curated celltypes from each tissue

TSHZ2 TRBV6-5

2.16e-03129242426dfed68ce7ccc38d02e671e722e201f9eb1ce0
ToppCellCOVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type

TSHZ2 DNAH9

2.16e-0312924257b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SORCS2 NR3C2

2.19e-0313024256b9c3325e011f1dbaf9efc71bd6e1af4f96fda6
ToppCellCOVID_non-vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

ANKRD30A MYO16

2.23e-031312425b29f0dc449b9fff5e8bf6365080168f31b7e268
ToppCellTCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9

CACNA1D TECTA

2.36e-03135242ac20133d4a36f48338b45bffb13e842cb66f83ad
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Aqp5_Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SORCS2 NR3C2

2.40e-031362428f5682422ba0b477c1e0700212948457f106cb10
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

DNAH9 TECTA

2.43e-031372425cb84392e4483f50e09fb7395e2ec98f3eb6ecf3
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NR3C2 TECTA

2.43e-03137242d346086f42d8f04d3fa67fe696834284acdc7080
ToppCellTracheal-10x5prime-Immune_Lymphocytic-T-T_CD8-gdT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

APOBEC3G TRBV6-5

2.47e-03138242769be787e24532d5e023f99f82c7272bddac40c3
ToppCellmetastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass

DNAH9 TECTA

2.57e-03141242399380de5ea09e22fd128e3e55fffeffc4874c15
ToppCellNS-critical-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

RAD51AP2 TSHZ2

2.57e-0314124233ad925ff7be3c682741a6328216a89f9d4033e9
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

DNAH9 TECTA

2.68e-03144242b622b605f7ec6083ec06c8ea0fd171e07c52f3de
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

C12orf54 SPINK5

2.68e-03144242f501e11b1d051ca67124137017a79a2d5bb6ae87
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

SORCS2 DNAH9

2.68e-0314424208005be9e3367f78ef27e125d9cce5ca53f4bd2d
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ANKRD30B CASK

2.72e-03145242734d85ca7a2e5e040f433cadc5f9be1f25cf2e91
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NR3C2 TECTA

2.72e-0314524278f5f4b96420c7f391e4d32a9ed151ed95fad90b
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ANKRD30B CASK

2.72e-031452428ba09eb0fd27f25aa90a3ad75d67a9f79f3f4f43
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 NFASC

2.72e-03145242051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SORCS2 NR3C2

2.79e-0314724264fa0753a3a79f492ef8acc6942bf90d379a983f
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANKRD30A ADAMTS20

2.83e-03148242d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell10x5'-blood-Myeloid_Mac-Intermediate_macrophages|blood / Manually curated celltypes from each tissue

SORCS2 CACNA1D

2.83e-03148242b801f38d249a02c4ceceb242cabbbc88418e5fd1
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M-IPC_like|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.

NFASC SPINK5

2.83e-03148242a261c6d3d9cf0311c053fca66c37d39e66db6ad8
ToppCell10x5'-blood-Myeloid_Mac|blood / Manually curated celltypes from each tissue

SORCS2 CACNA1D

2.83e-031482421ae2d7475e030e2de49940f3287b02953dbf3c65
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M-IPC_like-IPs_and_early_cortical_neurons|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.

NFASC SPINK5

2.83e-03148242c0237ba7d4040b6a497094b362dfb8b3a97a7d06
ToppCellInfluenza_Severe-Treg|World / Disease group and Cell class

PRMT9 CASK

2.87e-031492423250bb668319139451c31aa496b3ca1ed6750ce4
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Serpinf1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SORCS2 NR3C2

2.87e-031492425293c50b3fb41b1edaf9a97354899bd13770078c
ToppCellInfluenza_Severe-CD4+_T_naive|World / Disease group and Cell class

TSHZ2 MYO16

2.87e-03149242ce6552063510aa3e0b9d6e5b531eea67410e7056
ToppCell3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TSHZ2 SPINK5

2.90e-03150242aa11579a57d671a55e64183d35c1340fda6dec14
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 NFASC

2.90e-031502421270f33f9d7e46e55adf1a96e8beee858b95589d
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TSHZ2 C12orf54

2.90e-03150242909ccab92855f5f049dc29593aadab1ea973297b
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|390C / Donor, Lineage, Cell class and subclass (all cells)

APOBEC3G C12orf54

2.90e-03150242fdbfc8f743cf848978cf0488493f6df60be53982
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 NFASC

2.90e-03150242156118ce1d69522624196410cba18b8354cd0bb4
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 CACNA1D

2.90e-031502427a9d6a7ff8000e9a061e1b586e4c258cc91a2a09
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 CACNA1D

2.90e-03150242e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee
ToppCellTCGA-Breast|World / Sample_Type by Project: Shred V9

ANKRD30A ANKRD30B

2.90e-0315024208686ba1acac5c58667bf62e2af84c691d6bbdfb
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TSHZ2 MYO16

2.90e-03150242c922dbb4c9c12ccf08bd5f6168b20606c605d052
ToppCellCOVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANKRD30A ADAMTS20

2.90e-031502420205318a870e091add66ee4305747dda9f51510d
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CACNA1D NR3C2

2.90e-0315024287968ce885a4959616f0321f58517fe8029ba1b1
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SORCS2 NR3C2

2.94e-03151242f4f7156b2c0cfc78fd1841e07c9915d97ced561f
ToppCellVE-CD8-memory_CD4|VE / Condition, Cell_class and T cell subcluster

C12orf54 TECTA

2.98e-031522429401b7770c1bdc87eba25e82922f5dd1c4fa37ee
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

NFASC C12orf54

3.02e-03153242ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee
ToppCellE15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SYNJ1 TSHZ2

3.06e-03154242e65e4636646164610f33f7bbac0d879a3ea55986
ToppCellInfluenza_Severe-Treg|Influenza_Severe / Disease group and Cell class

PRMT9 CASK

3.06e-0315424277845bcb243aa1b1f1ca00f9ef2ae1b4d1bd3696
ToppCellURO-Lymphocyte-T_NK-CD4_Naive|URO / Disease, Lineage and Cell Type

TSHZ2 MYO16

3.06e-031542426c214ad5cbbfa8bab3f76b593cb598dfb914b566
ToppCellfacs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORCS2 TSHZ2

3.06e-0315424237765512dfae557b9f6eb30a29463b93682a4404
ToppCell390C-Lymphocytic-NK_cells-NK_cell_E|390C / Donor, Lineage, Cell class and subclass (all cells)

BBS9 PRMT9

3.10e-0315524298d8432739965dd1ab77c899cb6321f7f05eaa46
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 NFASC

3.14e-03156242363f1b661048d25895e2b8681c82894c957b29c0
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 NFASC

3.14e-03156242d5207dbfbcfb885557ea1378dfe6a56d7102e94a
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

PRMT9 SUZ12

3.14e-031562420f2147abcf31a26ee5b2f4d8c5d72232612a33f0
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PRMT9 SUZ12

3.14e-03156242cb87f12443fdc5538b856f765fcbac9406044e10
ToppCellInfluenza_Severe-CD4+_Tcm|World / Disease group and Cell class

MYO16 CASK

3.18e-03157242842ac087d3d51dba3a6b6937733b73a81aa15e1b
ToppCelldroplet-Liver-Hepatocytes-24m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORCS2 BBS9

3.18e-0315724216581e2399a211633f870dce326c75ff4b6a5fe6
ToppCelldroplet-Liver-Hepatocytes-24m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORCS2 BBS9

3.18e-03157242cbb08d5c151f0622123276926a2a15bb7d271e90
ToppCellsevere-CD4+_T_naive|World / disease stage, cell group and cell class

TSHZ2 NR3C2

3.18e-03157242ccf9abe0b59e9ea728cec4bba1872ffe14c7385c
Drugbutylparaben

NCOA2 CACNA1D NR3C2 CASK

1.74e-05157234ctd:C038091
DrugNimodipine

CACNA1D NR3C2

3.50e-059232DB00393
DrugLactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A

SYNJ1 NCOA2 BBS9 SPINK5

4.07e-051952343246_UP
DrugRauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A

SYNJ1 CACNA1D BBS9 APOBEC3G

4.15e-051962342778_UP
DrugVitexin [3681-93-4]; Up 200; 9.2uM; HL60; HT_HG-U133A

BBS9 APOBEC3G NR3C2 CASK

4.32e-051982342155_UP
DrugCalycanthine [595-05-1]; Up 200; 11.6uM; PC3; HT_HG-U133A

SYNJ1 CACNA1D BBS9 NR3C2

4.49e-052002345744_UP
DrugFelodipine

CACNA1D NR3C2

5.34e-0511232DB01023
DrugAndrogen Antagonists

CACNA1D NR3C2 CASK

5.80e-0575233ctd:D000726
Drugcorticoid

NCOA2 NR3C2

6.40e-0512232CID000066249
Drugdexamethasone 21-mesylate

NCOA2 NR3C2

1.16e-0416232CID000063041
DrugIl 11

NR3C2 C12orf54

1.32e-0417232CID000146069
Drugefonidipine

CACNA1D NR3C2

1.32e-0417232CID000119170
DrugAC1L9N61

NCOA2 NR3C2 SUZ12

1.45e-04102233CID000449471
DrugIsradipine

NCOA2 CACNA1D

1.48e-0418232ctd:D017275
Diseasesevere acute respiratory syndrome, COVID-19

SORCS2 NCOA2 BBS9 NFASC CASK

1.66e-05447225EFO_0000694, MONDO_0100096
Diseaseplatelet reactivity measurement, response to clopidogrel

SYNJ1 NR3C2

1.33e-0423222EFO_0004985, GO_1903493
DiseaseLarge cell carcinoma of lung

TRRAP CASK

2.60e-0432222C0345958
Diseasetriglyceride measurement, response to diuretic

TSHZ2 MYO16

2.93e-0434222EFO_0004530, GO_0036270
DiseaseAdenoma

CACNA1D SUZ12

3.29e-0436222C0001430
DiseaseAdenoma, Microcystic

CACNA1D SUZ12

3.29e-0436222C0205648
DiseaseAdenoma, Monomorphic

CACNA1D SUZ12

3.29e-0436222C0205649
DiseaseAdenoma, Basal Cell

CACNA1D SUZ12

3.29e-0436222C0205646
DiseaseFollicular adenoma

CACNA1D SUZ12

3.29e-0436222C0205647
DiseasePapillary adenoma

CACNA1D SUZ12

3.29e-0436222C0205650
DiseaseAdenoma, Trabecular

CACNA1D SUZ12

3.29e-0436222C0205651
Diseaseresponse to trauma exposure

NCOA2 BBS9

6.62e-0451222EFO_0008483
Diseasemelanoma

TRRAP ADAMTS20 SUZ12

8.03e-04248223C0025202
Diseaseurate measurement, bone density

TSHZ2 DNAH9 MYO16 NR3C2

1.04e-03619224EFO_0003923, EFO_0004531
DiseaseMicrocephaly

TRRAP CASK

1.14e-0367222C0025958
Diseasecortical thickness

NCOA2 ADAMTS20 BBS9 MYO16 UBN1

1.17e-031113225EFO_0004840
Diseasehypertension

SORCS2 CACNA1D NR3C2

1.48e-03307223EFO_0000537
Diseasecentral corneal thickness

ADAMTS20 BBS9 NR3C2

1.51e-03309223EFO_0005213
Diseaseresponse to anticonvulsant

SORCS2 ADAMTS20

1.82e-0385222GO_0036277
DiseaseAlzheimer disease, age at onset

SYNJ1 MYO16 NR3C2

2.04e-03343223EFO_0004847, MONDO_0004975
Diseasesubcutaneous adipose tissue measurement

RAD51AP2 NR3C2

2.18e-0393222EFO_0004766

Protein segments in the cluster

PeptideGeneStartEntry
EKLYQTMDTHCQNEM

PRMT9

551

Q6P2P2
TQCQMKKAEHMYQNE

ANKRD30B

1271

Q9BXX2
RATMKIMNYDEFQHC

APOBEC3G

146

Q9HC16
TQCQMKEAEHMYQNE

ANKRD30A

1291

Q9BXX3
HTYSNMNEDLNVMKE

ADAMTS20

216

P59510
ENFYEVNMHSQDLNM

RAD51AP2

751

Q09MP3
VSHDQMMQDISNNEY

CASK

791

O14936
NEEKMHQSAMYELCQ

NR3C2

836

P08235
EQLCVNMTNEKMHHY

MYO16

791

Q9Y6X6
DQEMCHEFQAFMKNG

SPINK5

26

Q9NQ38
EHGNQCQMKLMYEHN

BBS9

116

Q3SYG4
NVMLQDMQTDYSCNA

NFASC

201

O94856
SQQVQQMHEEFQEMY

DNAH9

476

Q9NYC9
CLAMQHYEQSKMFND

CACNA1D

1221

Q01668
ADIQMVNFDYHQMVK

SYNJ1

326

O43426
VYAQMHNEKEQEMTS

SORCS2

1111

Q96PQ0
MAQHPCQDQEQKVEM

C12orf54

1

Q6X4T0
DNQEAHQKYETMQCF

NCOA2

216

Q15596
SQYAAMCDNVHIQKM

TECTA

1671

O75443
QMNHACMLFVENYGQ

SUZ12

631

Q15022
NEAHNCMDKMTAVYA

TSHZ2

116

Q9NRE2
MPEQMAKYQDECQAH

UBN1

456

Q9NPG3
PNSFNDKFCDQMMQH

TRRAP

1456

Q9Y4A5
QSMTLQCAQDMNHEY

TRBV6-5

36

A0A0K0K1A5